SAN FRANCISCO -- In early trading on the Nasdaq today, Healtheon (HLTH) found itself most down at the open, recently off 6 5/16, or 8%, at 74. Its fall follows a report in this week's Barron's that Microsoft (MSFT) - Get Microsoft Corporation (MSFT) Report is looking to sell a portion of its stake in privately held WebMD before WebMD's merger with Healtheon is completed.
According to the article, Microsoft plans to sell a stake in WebMD equivalent to around 1.8 million shares of Healtheon for 52 a share, far below the 80 5/16 level at which Healtheon closed Friday. In early trading, Microsoft was up 3/4, or 1%, at 85 11/16.
was up 1 1/8, or 1%, at 103 15/16 this morning, reversing its
Friday fall that was precipitated by some cautious words from
analyst Henry Blodget. Blodget wrote that proliferation of alternative Internet access models could prevent AOL from "excessively" beating analysts' earnings estimates as it has done in the past.
reiterated that AOL was one of its "Magnificent Seven" large-cap growth stocks that have earned top ratings based on Prudential's new growth-stock model. AOL scored highest of the stocks ranked. In early trading,
After its strong
opened weaker today. The supplier of high-capacity voice and video networking equipment closed up nearly 200% Friday. It was down 5 1/2, or 6%, at 93 3/8 in early trading today.
The Heard on the Street column in today's
Wall Street Journal
chose to look at an IPO that didn't soar Friday. The column focuses on
, which was priced at 14 and closed at 14 Friday. internet.com was down 1, or 7%, at 13 in early trading.
was weaker on news that the company filed a $250 million offering with the
. The proceeds will be used to pay for advertising, new computers and possible acquisitions. Ameritrade was down 2 1/2, or 3%, at 83 early on.
were out with positive ratings on the Internet strategy and consulting company. Lead underwriter Merrill Lynch began coverage with a near-term accumulate rating and a long-term buy rating, along with a 12-month price target of 23. Also,
Donaldson Lufkin & Jenrette
began coverage of the stock with a buy rating. iXL was up 1/2, or 2.5%, at 20 1/2 in early trading.